Skip to content

Diamedix 720-400

by Diamedix Corp.

Diamedix 720-400 is a Class II device made by Diamedix Corp., cleared under FDA 510(k) K981867 on 28 Sep 1998 and listed in FDA GUDID since 20 Sep 2016 (UDI-DI 00817273020228), active as of 22 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

510(k) K981867

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00817273020228 UDI-DI Date20 Sep 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK981867 Date28 Sep 1998DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K981867 decided 28 Sep 1998 Active
  • FDA GUDID UDI-DI 00817273020228 listed 20 Sep 2016 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K981867
  2. Listed FDA GUDID 00817273020228

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Diamedix
Generic name
Measles virus immunoglobulin G (IgG) antibody IVD, kit, complement fixation test (CFT)
Model / reference
720-400
Description
"720-400 anti-Cardiolipin IgG/IgM Test Kit"
Primary DI / UDI-DI
00817273020228
510(k) Number
FDA product code
LFY
GMDN term
Measles virus immunoglobulin G (IgG) antibody IVD, kit, complement fixation test (CFT)
Device class
Class II
Regulation number
866.3900
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code LFY (Enzyme Linked Immunoabsorbent Assay, Varicella-Zoster).

Other devices from Diamedix Corp.

See all devices from Diamedix Corp. →

Properties

  • Lot / batch number
Other properties (14, all answered No)